| Literature DB >> 27150017 |
Kohei Yamamizu1, Alexei A Sharov1, Yulan Piao1, Misa Amano1, Hong Yu1, Akira Nishiyama1, Dawood B Dudekula1, David Schlessinger1, Minoru S H Ko1,2.
Abstract
Mouse embryonic stem cells (ESCs) can differentiate into a wide range - and possibly all cell types in vitro, and thus provide an ideal platform to study systematically the action of transcription factors (TFs) in cell differentiation. Previously, we have generated and analyzed 137 TF-inducible mouse ESC lines. As an extension of this "NIA Mouse ESC Bank," we generated and characterized 48 additional mouse ESC lines, in which single TFs in each line could be induced in a doxycycline-controllable manner. Together, with the previous ESC lines, the bank now comprises 185 TF-manipulable ESC lines (>10% of all mouse TFs). Global gene expression (transcriptome) profiling revealed that the induction of individual TFs in mouse ESCs for 48 hours shifts their transcriptomes toward specific differentiation fates (e.g., neural lineages by Myt1 Isl1, and St18; mesodermal lineages by Pitx1, Pitx2, Barhl2, and Lmx1a; white blood cells by Myb, Etv2, and Tbx6, and ovary by Pitx1, Pitx2, and Dmrtc2). These data also provide and lists of inferred target genes of each TF and possible functions of these TFs. The results demonstrate the utility of mouse ESC lines and their transcriptome data for understanding the mechanism of cell differentiation and the function of TFs.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27150017 PMCID: PMC4858678 DOI: 10.1038/srep25667
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Induction of transcription factors (TFs) and its effect on the transcriptome.
(a) Vector carrying a tetracycline-inducible (Tet-Off) transgenic TF was integrated into stably expressed Rosa26 locus in the genome. (b) Proportion of Venus-positive cells was evaluated by FACS (Dlx4 clone). (c) Scheme of experiment: To activate the transgenic TF, Dox was removed from the media. Forty-eight hours later, RNA was collected from manipulated cells, and gene expression was quantified with microarrays via comparison with control cells that were continuously cultured in Dox+ conditions. (d) Example of a scatterplot comparing gene expression profiles with or without Dox for Dlx2 induction. (e) Principal Component Analysis (PCA) of gene expression change in ES cells after induction of transcription factors; red – 48 new TFs analyzed in this paper; green – 137 TFs analyzed before3. Analysis is based on genes with significant change of expression (FDR ≤ 0.05, change ≥ 1.5 fold). (f) Number of genes with significant change of their expression after the induction of individual transcription factors.
Figure 2Correlation of gene expression response to the induction of transcription factors (this study) with tissue-specific gene expression from the GNF ver. 3 database; color shows z-value for correlation significance, white = non-significant correlation (z < 2).
Figure 3Validation of the capacity of TFs to facilitate ESC differentiation and activate target genes.
(a) Analysis of the proportion of cells with neural-progenitor marker PSA-NCAM after induction of three TFs (Myt1, Isl1, and St18) for 6 days (3 days in α MEM abd 3 days in neuroCult) by FACS analysis; TFs were induced in Dox− conditions, whereas cells cultured in Dox+ conditions were used as control. (b) Average proportion of PSA-NCAM-positive cells after induction of three TFs in three replications. (c) Rank plot analysis for enrichment of target genes bound by transcription factors (TFs) in promoters (0–0.5 Kb from TSS) or enhancers (0.5–50 Kb from TSS) among genes upregulated after induction of these TFs. Genes were sorted by expression changes and then the proportion of target genes was estimated in a sliding window of 300 genes. Statistical significance was evaluated using PAGE13.
Summary table for the parametric analysis of gene set enrichment, PAGE13, for genes upregulated after induction of individual transcription factors*.
| TF | Gene Ontology (GO) | Genetic Association Database (GAD) |
| Barhl2 | Collagen, skeleton | Skeleton, aorta, limb |
| Dlx2 | Neuron, ear, limb | Ear, limb, jaw |
| Dlx4 | Gap junction, brain | Brain |
| E2f1 | Chorion, neuropeptide | |
| Esrrg | Epithelium, synapse, estrogen | |
| Etv2 | Angiogenesis, lymph vessel, heart | Embryo growth, aorta, neural crest |
| Fezf2 | Neuron apoptosis, synapse | Brain, olfactory bulb, synapse |
| Foxn4 | Brain, limb | Skeleton, vertebra |
| Glis2 | Interferon, synapse | |
| Hey2 | Symporter activity, interferon | Inflammation |
| Hoxb1 | Skeleton, spinal cord | Neurogenesis, skeleton |
| Hoxb4 | Pituitary | |
| Hoxc9 | Synapse | Synapse, Purkinje cells |
| Isl1 | Limb, sympathetic system | Limb, sympathetic ganglion |
| Lhx8 | Ear, neuron | Ear, hippocampus, hypothalamus, hair |
| Lin28 | Interferon | |
| Lmx1a | Brain, sympathetic system | Brain, cerebellum |
| Msx1 | Retina, adrenal gland | Muscle, synapse |
| Msx3 | Muscle, synapse | |
| Myb | Germ cells | Myogenesis |
| Myt1 | Heart, synapse, myelin | Nervous system |
| Nkx2-3 | Eye, cytolysis | Eye |
| Nkx6-3 | Eye | Lens, forebrain |
| Pax6 | Calcium, face, renal system | Liver, ovary |
| Pdx1 | Angiogenesis, brain | Ear, telencephalon |
| Pitx1 | Collagen, skeleton, muscle, skin | Skeleton, teeth, ovary |
| Pitx2 | Collagen, extracellular matrix, insulin | Skeleton, teeth, ovary |
| Sall2 | Voltage gated ion channel | |
| Sry | Male sex determination | |
| St18 | Hippocampus | |
| Tbx6 | Somitogenesis, brain, heart | Chorion, heart |
| Tcfap4 | Interferon, brain | Skin |
*See Supplementary Tables S1 and S2 for details and statistics.